From: Identifying the status of genetic lesions in cancer clinical trial documents using machine learning
Gene | Two-stage classifier | Single-stage classifier |
---|---|---|
ALK | 88.2% | 88.1% |
BRAF | 85.4% | 85.4% |
EGFR | 82.5% | 82.0% |
KIT | 75.9% | 75.2% |
KRAS | 87.5% | 87.5% |
MET | 93.0% | 92.5% |
PTEN | 73.9% | 71.3% |
WT1 | 83.5% | 83.5% |
Average | 83.7% | 83.2% |